UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Plinabulin (Plin), a novel non-G-CSF molecule for the revention of chemotherapy-induced neutropenia (CIN), has the potential to positively impact tumor micro environment

Annals of oncology, 2018-10, Vol.29, p.viii604-viii604

2018

Volltextzugriff (PDF)

1708P Severe neutropenia (grade 4, Gr4N) as a population-based predictor for adverse clinical outcome of chemotherapy induced neutropenia (CIN)

Annals of oncology, 2021-09, Vol.32, p.S1189-S1190

2021

Volltextzugriff (PDF)

1709P Prediction of febrile neutropenia (FN), hospitalization (Hosp) rates, and infection (Inf) rates in chemotherapy-induced neutropenia (CIN) patients (pts) treated with the plinabulin and pegfilgrastim combination (Plin+Peg) using a meta-analysis (MA)-based tool

Annals of oncology, 2021-09, Vol.32, p.S1190-S1190

2021

Volltextzugriff (PDF)

276MO Superior single agent effectiveness with plinabulin (Plin) versus (vs) placebo (Plac) for docetaxel (Doc)-induced neutropenia (DIN) prevention in non-small cell lung cancer (NSCLC) patients (pts)

Annals of oncology, 2022-11, Vol.33, p.S1541-S1541

2022

Volltextzugriff (PDF)

1813P - The effect of increasing doses of pegfilgrastim (Peg) on thrombocytopenia (T) in breast cancer (BC) patients (pts) receiving taxotere (Doc), doxorubicin, cyclophosphamide (TAC) and plinabulin (Plin)

Annals of oncology, 2019-10, Vol.30, p.v737-v737

2019

Volltextzugriff (PDF)

The effect of increasing doses of pegfilgrastim (Peg) on thrombocytopenia (T) in breast cancer (BC) patients (pts) receiving taxotere (Doc), doxorubicin, cyclophosphamide (TAC) and plinabulin (Plin)

Annals of oncology, 2019-10, Vol.30, p.v737

2019

Volltextzugriff (PDF)

1813PThe effect of increasing doses of pegfilgrastim (Peg) on thrombocytopenia (T) in breast cancer (BC) patients (pts) receiving taxotere (Doc), doxorubicin, cyclophosphamide (TAC) and plinabulin (Plin)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

1686PDPlinabulin (Plin), a novel non-G-CSF molecule for the revention of chemotherapy-induced neutropenia (CIN), has the potential to positively impact tumor micro environment

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

P1.01-06 Plinabulin, a Novel Immuno-Oncology Agent Mitigates Docetaxel Chemotherapy -Induced-Neutropenia and -Thrombocytopenia in NSCLC Patients

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S461-S461

2018

Volltextzugriff (PDF)

A randomized clinical trial of the combination of Plinabulin (Plin) + Pegfilgrastim (Peg) versus (vs) Peg alone for TAC (docetaxel, doxorubicin, cyclophosphamide) induced Neutropenia (CIN)

Breast (Edinburgh), 2019-03, Vol.44, p.S21

2019

Volltextzugriff (PDF)

P017 - A randomized clinical trial of the combination of Plinabulin (Plin) + Pegfilgrastim (Peg) versus (vs) Peg alone for TAC (docetaxel, doxorubicin, cyclophosphamide) induced Neutropenia (CIN)

Breast (Edinburgh), 2019-03, Vol.44, p.S21-S21

2019

Volltextzugriff (PDF)

The use of generalized tests in medical research

Journal of biopharmaceutical statistics, 1998, Vol.8 (4), p.497-508

Ogenstad, Stephan

1998

Volltextzugriff (PDF)

Analysis and design of repeated measures in clinical trials using summary statistics

Journal of biopharmaceutical statistics, 1997, Vol.7 (4), p.593-604

Ogenstad, Stephan

1997

Volltextzugriff (PDF)

Combined Treatment of Acute EAE in Lewis Rats with TNF-Binding Protein and Interleukin-1 Receptor Antagonist

Experimental neurology, 1998-02, Vol.149 (2), p.455-463

1998

Volltextzugriff (PDF)

Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infection

Antimicrobial Agents and Chemotherapy, 1989-07, Vol.33 (7), p.1023-1031

1989

Volltextzugriff (PDF)

Intrapleural administration of 0.25%, 0.375%, and 0.5% bupivacaine with epinephrine after cholecystectomy

Anesthesia and analgesia, 1988-05, Vol.67 (5), p.430-434

1988

Volltextzugriff (PDF)

Interaction study between remoxipride and biperiden

Psychopharmacologia, 1993-04, Vol.111 (1), p.27-32

1993

Volltextzugriff (PDF)

No effect of remoxipride on the QT interval and QTc-results from a comparison of 3 dose ranges of remoxipride and haloperidol

European neuropsychopharmacology, 1991, Vol.1 (3), p.430-431

1991

Volltextzugriff (PDF)

Remoxipride―a new potential antipsychotic drug: pharmacological effects and pharmacokinetics following repeated oral administration in male volunteers

Psychopharmacologia, 1988-01, Vol.95 (2), p.157-161

1988

Volltextzugriff (PDF)

Effect of zimeldine and its metabolites on [3H]thymidine incorporation in lymphocyte cultures from psychiatric patients with or without a hypersensitivity reaction during zimeldine therapy

International clinical psychopharmacology, 1994-09, Vol.9 (3), p.179-186

1994

Volltextzugriff (PDF)

Lymphocyte function in untreated Hodgkin's disease: An important predictor of prognosis

British journal of cancer, 1982-01, Vol.45 (1), p.70-79

1982

Volltextzugriff (PDF)

Drug interaction studies with remoxipride

Acta psychiatrica Scandinavica, 1990-01, Vol.82 (S358), p.58-62

1990

Volltextzugriff (PDF)

Remoxipride imipramine interaction

European neuropsychopharmacology, 1991, Vol.1 (3), p.431-432

1991

Volltextzugriff (PDF)

Pressor response of oral tyramine in healthy men given amiflamine and placebo

Clinical pharmacology and therapeutics, 1986-08, Vol.40 (2), p.155-160

1986

Volltextzugriff (PDF)

Blood T-Lymphocyte Functions in Healthy Adults in Relation to Age

Scandinavian Journal of Haematology, 1982-01, Vol.28 (1), p.45-53

1982

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(52)

Publikationsform

Sprache

Englisch
(62)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Plinabulin (Plin), a novel non-G-CSF molecule for the revention of chemotherapy-induced neutropenia (CIN), has the potential to positively impact tumor micro environment

1708P Severe neutropenia (grade 4, Gr4N) as a population-based predictor for adverse clinical outcome of chemotherapy induced neutropenia (CIN)

1709P Prediction of febrile neutropenia (FN), hospitalization (Hosp) rates, and infection (Inf) rates in chemotherapy-induced neutropenia (CIN) patients (pts) treated with the plinabulin and pegfilgrastim combination (Plin+Peg) using a meta-analysis (MA)-based tool

276MO Superior single agent effectiveness with plinabulin (Plin) versus (vs) placebo (Plac) for docetaxel (Doc)-induced neutropenia (DIN) prevention in non-small cell lung cancer (NSCLC) patients (pts)

1813P - The effect of increasing doses of pegfilgrastim (Peg) on thrombocytopenia (T) in breast cancer (BC) patients (pts) receiving taxotere (Doc), doxorubicin, cyclophosphamide (TAC) and plinabulin (Plin)

The effect of increasing doses of pegfilgrastim (Peg) on thrombocytopenia (T) in breast cancer (BC) patients (pts) receiving taxotere (Doc), doxorubicin, cyclophosphamide (TAC) and plinabulin (Plin)

1813PThe effect of increasing doses of pegfilgrastim (Peg) on thrombocytopenia (T) in breast cancer (BC) patients (pts) receiving taxotere (Doc), doxorubicin, cyclophosphamide (TAC) and plinabulin (Plin)

1686PDPlinabulin (Plin), a novel non-G-CSF molecule for the revention of chemotherapy-induced neutropenia (CIN), has the potential to positively impact tumor micro environment

P1.01-06 Plinabulin, a Novel Immuno-Oncology Agent Mitigates Docetaxel Chemotherapy -Induced-Neutropenia and -Thrombocytopenia in NSCLC Patients

A randomized clinical trial of the combination of Plinabulin (Plin) + Pegfilgrastim (Peg) versus (vs) Peg alone for TAC (docetaxel, doxorubicin, cyclophosphamide) induced Neutropenia (CIN)

P017 - A randomized clinical trial of the combination of Plinabulin (Plin) + Pegfilgrastim (Peg) versus (vs) Peg alone for TAC (docetaxel, doxorubicin, cyclophosphamide) induced Neutropenia (CIN)

The use of generalized tests in medical research

Analysis and design of repeated measures in clinical trials using summary statistics

Combined Treatment of Acute EAE in Lewis Rats with TNF-Binding Protein and Interleukin-1 Receptor Antagonist

Pharmacokinetics of foscarnet and distribution to cerebrospinal fluid after intravenous infusion in patients with human immunodeficiency virus infection

Intrapleural administration of 0.25%, 0.375%, and 0.5% bupivacaine with epinephrine after cholecystectomy

Interaction study between remoxipride and biperiden

No effect of remoxipride on the QT interval and QTc-results from a comparison of 3 dose ranges of remoxipride and haloperidol

Remoxipride―a new potential antipsychotic drug: pharmacological effects and pharmacokinetics following repeated oral administration in male volunteers

Effect of zimeldine and its metabolites on [3H]thymidine incorporation in lymphocyte cultures from psychiatric patients with or without a hypersensitivity reaction during zimeldine therapy

Lymphocyte function in untreated Hodgkin's disease: An important predictor of prognosis

Drug interaction studies with remoxipride

Remoxipride imipramine interaction

Pressor response of oral tyramine in healthy men given amiflamine and placebo

Blood T-Lymphocyte Functions in Healthy Adults in Relation to Age

Suchergebnisse filtern